Interventional Radiology Market Set for Strong Growth to USD 51.6 Billion by 2035, Led by North America's 43.1% Market Share | Key Players - Siemens Healthineers, GE Healthcare, Medtronic

Leander Texas -
The Interventional radiology market was estimated at USD 30.8 billion in 2025. The market is expected to grow from USD 32.8 billion in 2026 to USD 51.6 billion in 2035, at a CAGR of 5.3% during the forecast period,According to teh latest report published by DataM Intelligence.

The market's growth is driven by rising demand for minimally invasive procedures and advanced imaging tech in the US, alongside strategic collaborations like Interventional Systems' partnership with Siemens Healthineers to enhance robotics in angiography suites. In Japan, increased uptake of image-guided therapies and hospital investments in IR infrastructure further boost expansion.

Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/interventional-radiology-market?prtk

Key Industry Development

United States
✅ December 2025: Siemens Healthineers launched Optiq AI, an advanced imaging pipeline integrated into angiography systems for real-time noise reduction and automated exposure optimization during complex neurovascular and peripheral interventions.This enhances procedural precision by 25% and reduces radiation exposure for high-volume U.S. cath labs.

✅ October 2025: GE HealthCare expanded its OmnifyXR suite installations nationwide following FDA validation for broader interventional applications like tumor ablations and vascular embolizations.The AR-guided system cuts procedure times by up to 30%, boosting adoption in ambulatory centers.

✅ May 2025: Merit Medical Systems acquired Biolife Delaware for $120 million, integrating advanced hemostatic devices such as StatSeal discs optimized for post-interventional radiology access site management.This strengthens U.S. market share in closure technologies amid rising outpatient procedures.

✅ January 2025: Esaote Group debuted the e-SPADES AI platform and MyLab C30 ultrasound system at major radiology conferences, targeting real-time guidance for biopsies and drainages.These tools improve workflow efficiency in community hospitals serving aging populations.

Japan: Key Industry Developments
✅ November 2025: Canon Medical Systems rolled out the Alphenix Sky+ C-arm with enhanced 3D-CT capabilities for precise interventional oncology procedures, approved by PMDA for nationwide deployment.It supports minimally invasive tumor treatments, aligning with Japan's precision medicine initiatives.

✅ September 2025: Terumo Corporation introduced the Radifocus Introducer II GlideSheath for radial access in interventional radiology, featuring hydrophilic coating to minimize complications in vascular cases.This addresses rising demand from Japan's cardiovascular patient base in hybrid ORs.

✅ July 2025: Olympus launched the EVIS X1 endoscopy-integrated radiology scope for combined diagnostic-interventional workflows, gaining rapid MHLW reimbursement approval.The system facilitates earlier cancer detection and treatment in high-prevalence regions.

✅ March 2025: Fujifilm enhanced its Synapse 3D platform with AI-driven vessel analysis for stroke interventions, deployed across major Tokyo hospitals.It reduces analysis time by 40%, supporting Japan's neurointerventional expansion.

Strategic Mergers and Acquisitions:

GE HealthCare acquired Intelerad (announced November 2025, $2.3 billion cash, expected close H1 2026): Targets cloud-based PACS and AI imaging for radiology/cardiology; rationale includes expanding outpatient/ambulatory footprint, accelerating SaaS revenue, and integrating AI for unified inpatient-outpatient workflows.

Merit Medical acquired Biolife Delaware (May 2025, $120 million cash): Adds hemostatic devices (StatSeal, WoundSeal) for post-IR procedure bleeding control in oncology, vascular access, and spine; strategic fit expands portfolio, adds $18 million annual revenue, and taps $350 million global market.

Mosaic Clinical Technologies (Radiology Partners) acquired Cognita Imaging (November 2025, value undisclosed): Integrates AI vision language models for radiology diagnostics; aims to address radiologist shortages, boost accuracy/speed, and scale via MosaicOS platform amid rising imaging demand.

Major Players:-
GE HealthCare | Siemens Healthineers | Canon Medical Systems | Koninklijke Philips | Fujifilm | Shimadzu Corporation

GE HealthCare - GE holds roughly 21% of the global imaging market, often topping rankings due to its broad portfolio of CT, MRI, ultrasound and advanced image-guided therapy systems. Its strong R&D and AI-enhanced platforms support precise interventional procedures, boosting adoption in hospitals worldwide.

Siemens Healthineers - With an estimated 19% market share, Siemens leads through cutting-edge angiography and hybrid imaging solutions. It integrates AI and precision imaging into interventional X-ray and workflow systems, strengthening its position in cardiovascular and minimally invasive therapies.

Koninklijke Philips - Philips captures around 19% share by focusing on AI-enabled image-guided therapy and enterprise imaging workflows. Its strong global reach and digital health platforms streamline interventional radiology across oncology, vascular, and diagnostic segments.

Canon Medical Systems - Canon holds about 9% of the broader imaging market, rooted in high-quality CT, MRI, and interventional imaging solutions that emphasize dose reduction, workflow efficiency and 4D vascular imaging. These innovations improve clinical precision for IR procedures.

Fujifilm & Shimadzu - Fujifilm (8%) excels in advanced digital radiography and portable interventional systems, blending IT and AI to enhance procedural planning and image clarity. Shimadzu (7%) specializes in X-ray and angiography systems, offering reliable image-guided tools used in minimally invasive radiology worldwide.

"Secure your 30% discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=interventional-radiology-market?prtk (Purchase 2 or more Repots and get 50% Discount)

Market Segmenatation-

Product Segmentation: In the US interventional radiology market, segmentation by product includes devices such as catheters, stents, angiography & angioplasty systems, embolization and biopsy devices, ablation tools and other imaging-guided instruments, where stents and angiography equipment hold significant market share due to high procedural demand in cardiovascular and oncologic care. In Japan, the product segment is similarly stratified with MRI systems (leading 39% share), CT scanners, ultrasound imaging and angiography systems reflecting sustained capital investment in image-guided therapy platforms tailored to an aging population that drives demand for minimally invasive diagnostics and treatment.

Procedure Segmentation: Procedurally, the US market is classified into angiography, balloon angioplasty, embolization, biopsy, vertebroplasty/kyphoplasty and ablation procedures, with angiography and angioplasty dominating due to high prevalence of cardiovascular disease and interventional adoption. In Japan, procedures are segmented into angioplasty, biopsy, embolization, thrombolysis, vertebroplasty, nephrostomy and MSK and oncology interventions, where rising incidence of vascular and spinal disorders has expanded utilization of catheter-based and tumor ablation techniques.

Application Segmentation: US interventional radiology applications are grouped into cardiology, oncology, urology & nephrology, gastroenterology and other specialties, with cardiology historically dominating share while oncology applications are among the fastest-growing due to increasing cancer incidence. In Japan, key application segments mirror global clinical needs with cardiology, oncology, urology, gastroenterology, and obstetrics/gynecology, where cardiovascular and cancer interventions are major revenue drivers within advanced hospital settings.

End-User Segmentation: In the US market, end users include hospitals, ambulatory surgical centers (ASCs), diagnostic imaging centers and specialty clinics, with hospitals holding the largest share due to established infrastructure and high procedural volumes, while ASCs gain traction for mid-complexity interventions. In Japan, segmentation by end users also emphasizes hospitals as the dominant segment (45% share) given their advanced imaging suites, with clinics and ambulatory surgical centers expanding as interventional radiology moves into less complex outpatient settings.

Market Drivers:

• Rising Burden of Cardiovascular and Oncological Diseases: In the United States, heart disease remains the leading cause of death, with over 695,000 deaths annually, increasing demand for minimally invasive angioplasty and embolization procedures. In Japan, where nearly 29% of the population is aged 65+, higher incidence of liver cancer and peripheral artery disease is accelerating adoption of image-guided interventions.

• Rapid Growth in Minimally Invasive Procedures: U.S. hospitals are increasingly shifting from open surgeries to catheter-based interventions to reduce hospital stays and costs, supported by strong reimbursement under Medicare. In Japan, clinical preference for less invasive therapies has expanded transcatheter arterial chemoembolization (TACE) and endovascular aneurysm repair procedures across tertiary hospitals.

• Advanced Imaging Infrastructure Expansion: The United States leads in installed base of CT and MRI systems, enabling high procedural volumes in interventional suites. Japan, one of the highest per capita users of diagnostic imaging systems globally, is integrating high-resolution fluoroscopy and hybrid operating rooms to improve procedural precision and safety.

• Government and Reimbursement Support for Image-Guided Therapies: In the U.S., CMS reimbursement codes for interventional oncology and vascular procedures continue to expand, improving hospital revenue streams. Japan's national health insurance system covers a broad range of catheter-based treatments, encouraging wider physician adoption and patient accessibility.

Regional insights:

North America (primarily US): 43.1%
(Still the largest share of the global interventional radiology market, driven by advanced imaging technologies, high procedural volumes and strong healthcare infrastructure with the United States accounting for the vast majority of the regional market.)

Asia Pacific (incl. Japan): 26%
(A substantial and growing share led by expanding healthcare investments and rising procedure volumes in major APAC countries. Japan contributes a meaningful portion of APAC demand with an IR market valued at approx. USD 1.6B in 2025.)

Europe: 28%
(Strong share supported by widespread adoption across established healthcare systems and increasing incidence of chronic diseases requiring minimally invasive interventions.)

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/interventional-radiology-market?prtk

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.